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Objective As we all know, exercise can enhance the will, improve the mood, and counteract the bad 
feelings of the body, but the cause and mechanism of action have not been clear. The 
endocannabinoid system is an important regulatory system in the central nervous system that 
regulates cognition, mood and behavior. Endocannabinoids can exert physiological regulation 
through cannabinoid receptor 1 (CB1) and cannabinoid receptor 2 (CB2). Cannabinoid receptors are 
widely distributed in the body and participate in the regulation of anti-nociceptive signals at multiple 
levels. This study will explore the role and mechanism of the endocannabinoid system in exercise-
induced antinociception by literature research methods. 
Methods Using endocannabinoid, exercise/sports and antinociception or emotion as keywords, 
using Pubmed, Medline, and Embase databases to search for nearly 15 years of research literature 
and the literatures from cross-references of journals, after excluding the literature that is not 
relevant to the research content, the 12 articles included were analyzed. 
Results Exercise can activate the endocannabinoid system, the degree of activation is related to 
exercise intensity, and high-intensity exercise significantly increases endocannabinoid levels in the 
human body. Cannabinoid receptor 1 (CB1) and cannabinoid receptor 2 (CB2) are widely distributed 
in the nervous system including the central nervous system and the peripheral nervous system. 
When exercise activates the endocannabinoid system, the increased endocannabinoid in the 
circulatory system activates CB1 and CB2 receptors, promotes hyperpolarization of the nervous 
system cells, reduces the rate of excitable cell release, and inhibits neurotransmitters, and reduce 
nociceptive impulses, thereby the body produces anti-nociception. Pretreatment with 
endocannabinoid metabolic enzyme inhibitors (MAFP, JZL184) and endocannabinoid reuptake 
inhibitors (VDM11) can be extended and enhanced the antinociceptive effect of exercise. 
Pretreatment with endocannabinoid receptor antagonists (AM251 and AM630) will inhibit the 
antinociception induced by aerobic exercise in mechanical and thermal nociceptive tests. 
Conclusions Exercise can enhance the level of circulating endocannabinoids, activate the 
endocannabinoid system through endocannabinoid receptors, and then induce the body to produce 
anti-nociceptive effects. The degree of activation is related to exercise intensity. Studying the role and 
mechanism of the endocannabinoid system in exercise-induced antinociception can provide a 
theoretical basis for exercise to improve depression, anxiety and other emotions, improve the sense 
of life and prevent mental disorders. 
 
